Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 6,666 shares at $42.40 ($286K) on 2018-01-03, disclosed to the SEC on 2018-01-04.
Open-market sale of $286k XLRN by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.86 | 300 | $12K | 4.3% |
| 2 | $42.40 | 2,300 | $98K | 34.1% |
| 3 | $43.33 | 2,033 | $88K | 30.8% |
| 4 | $43.33 | 2,033 | $88K | 30.8% |
| Total | $42.90 avg | 6,666 | $286K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |